OpSens Medical, a subsidiary of OpSens (TSX:OPS), was founded on the belief that our innovative fiber optic technologies would help to improve cardiovascular disease diagnosis and treatment. Today, our 2nd generation fiber optic OptoWire III has been used in over 250,000 patients worldwide and our game-changing SavvyWire launched in 2022 is transforming the way structural heart interventions are performed.
We pursue robust growth, through our own initiatives and key alliances with exemplary partners and commit ourselves to providing solutions to medical professional and patient needs.
Our Team continues to grow. Our Vision is to be a world leader in optical measurement in the field of medical instrumentation. Our Mission is to contribute to health with unique expertise in innovative medical products.